More about

Multiple Myeloma

News
October 02, 2024
3 min read
Save

Race, age linked to delayed treatment with oral antimyeloma therapies

The timing with which patients with newly diagnosed multiple myeloma began treatment with oral antimyeloma medications varied greatly by age and race, according to retrospective study results.

News
September 24, 2024
4 min read
Save

Novel technique may provide ‘incredible’ benefit to CAR T-cell therapy

A novel therapeutic approach may improve the persistence and functionality of chimeric antigen receptor T cells, helping to prevent relapse.

News
September 23, 2024
3 min read
Save

SGLT2s could prevent cardiotoxic effects of cancer therapies in patients with diabetes

SGLT2 inhibition may prevent cancer therapy-related cardiac dysfunction and improve other outcomes in patients with diabetes undergoing cancer therapy, researchers reported.

News
September 20, 2024
1 min read
Save

FDA approves isatuximab-irfc combination for certain adults with multiple myeloma

The FDA approved isatuximab-irfc in combination with bortezomib, lenalidomide and dexamethasone for treatment of certain adults with multiple myeloma.

News
September 11, 2024
3 min read
Save

Risk for second primary malignancies no greater with CAR-T than other standard therapies

Patients who received chimeric antigen receptor T-cell therapy did not exhibit increased risk for second primary malignancies compared with those who received other standard treatments, according to a systematic review and meta-analysis.

News
August 12, 2024
1 min read
Save

FDA approves IND application for Eque-cel T-cell therapy in SLE, lupus nephritis

The FDA has approved an investigational new drug application for Eque-cel, an autologous T-cell injection, in patients with systemic lupus erythematosus and lupus nephritis, according to a press release from the manufacturer.

News
July 31, 2024
1 min read
Save

Three women junior faculty named NCI K12 faculty scholars

Three Sylvester Comprehensive Cancer Center at University of Miami Miller School of Medicine women junior faculty members have been named NCI K12 2024 faculty scholars.

News
July 26, 2024
4 min read
Save

Findings highlight ‘critical importance’ of infectious complications after CAR-T

Infections are the primary cause of nonrelapse mortality among individuals who undergo chimeric antigen receptor T-cell therapy, according to study results.

News
July 24, 2024
4 min read
Save

Study of medical mistrust a 'crucial first step' to improving equitable access to care

Medical mistrust continues to be a major issue in the care of patients with multiple myeloma — particularly among Black individuals according to findings published in Cancer Medicine.

View more